Glessner Coleen 4
4 · Emergent BioSolutions Inc. · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
EBS EVP Coleen Glessner Receives 100,111 RSU Award
What Happened Coleen Glessner, EVP, Quality & Ethics (and Company PLC), was granted 100,111 restricted stock units (RSUs) on April 29, 2026. The Form 4 reports the award as an acquisition (code A) at $0.00 per unit (typical for RSU grants); no cash was exchanged at grant. The RSUs represent the right to receive one share of Emergent BioSolutions common stock per unit upon vesting.
Key Details
- Transaction date: April 29, 2026; filing date: May 1, 2026 (timely filed).
- Transaction type/code: Award/Grant (A); reported price $0.00 per RSU.
- Number of RSUs granted: 100,111.
- Shares owned after transaction: Not specified in the filing.
- Footnotes: Grant was approved by the Compensation Committee on March 2, 2026, contingent on shareholder approval of an amendment to the 2006 Stock Incentive Plan; shareholders approved the amended plan on April 29, 2026 (F1). RSUs vest in three annual installments beginning on the anniversary of approval, subject to continued service; each RSU converts to one share upon vesting (F2).
- Timeliness: Filing appears timely (reported within the Form 4 deadline).
Context RSU grants are standard long-term compensation — they are not immediate cash purchases or sales and only convert to shares as they vest. This award increases potential future share holdings if Glessner remains with the company through the vesting dates, but does not represent an immediate market purchase or sale.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-04-29+100,111→ 204,219 total
Footnotes (2)
- [F1]The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the "Company"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the "Amended Stock Incentive Plan"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026.
- [F2]Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.